This study is looking at a new approach for Alzheimer's disease and related memory problems. It tests a combination of 40Hz light therapy and cognitive therapy, delivered through an iPad application called ALZLIFE. The idea is that 40Hz light may help increase "gamma" brainwaves, which are important for brain function and are often reduced in Alzheimer's. This could potentially help clear harmful proteins in the brain. You might be able to join if you are 50 years or older and have Alzheimer's disease or cognitive impairment (problems with thinking and memory). You cannot have a history of seizures or significant eye disease like macular degeneration. The study will measure success by looking at your cognitive test results over about one year. The current status of this study is unclear.

Study design

This is an observational study planning to include 2000 participants. It is not specified if participants are randomly assigned to groups or if the study is blinded.

What's involved

The primary endpoint is an in-app cognitive test measured through study completion, which is an average of one year.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for an average of one year, which is the duration of the study completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.